Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12-Month, Phase 4, Open Label, Multicenter, Trial to Assess the Efficacy and Safety of COMBIGAN® in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG)

NCT02863705 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT02863705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02863705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12-Month, Phase 4, Open Label, Multicenter, Trial to Assess the Efficacy and Safety of COMBIGAN® in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG)
Lead sponsor
Allergan
Phase
Phase 4
Overall status
Completed
Start date
July 5, 2016
Completion date
July 25, 2018
Enrollment
118 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma, open-angle, normal tension glaucoma